SAB BIOTHERAPEUTICS, INC. (SABSW) Operating income 2020–2025
SAB BIOTHERAPEUTICS, INC. (SABSW) annual operating income history from SEC filings — each fiscal year as reported.
-$49.0MFY2025 · since FY2020: $20.6M → -$49.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$49.0M | -14.1% |
| FY2024 | -$42.9M | -12.7% |
| FY2023 | -$38.1M | -31.7% |
| FY2022 | -$28.9M | -115.9% |
| FY2021 | -$13.4M | -165.2% |
| FY2020 | $20.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice